The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (12 analysts) rates it hold, with a mean price target of $98.
T. Rowe Price TROW
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · T.
read at $121.68
T. Rowe Price holds its Markup at $121.68.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 33 days |
| Price | $121.68 |
| Valuation | 12.78 trailing · 11.75 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.50 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades at roughly a 2% discount to our $124.00 fair value, moderate competitive moat, 5.30% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the Street see limited upside at this price.
| Revenue growth | 5.30% |
| Profit margin | 28.28% |
| Debt to equity | 3.87 |
| Analyst consensus | Hold · 12 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its business activity screen. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Business activity: Financials sector Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Savings giant trips over its own ethics test
Every monthly contribution into a workplace pension or retail fund travels through an asset manager that still posts a 28 percent profit margin and 19 percent ROE. T. Rowe Price looks steady on paper, yet we pass without hesitation.
The forward multiple of 11.3 times earnings prices in only modest 5 percent revenue growth, and twelve analysts already mark the shares 9 dollars below where they trade today. A moderate moat does little to change the arithmetic when the ethical screen returns a clear fail on business activity grounds.
That single red flag overrides any narrow valuation cushion and keeps the name firmly on the avoid list. Analysis, not advice.
| Forward P/E | 11.8x expensive even after accounting for its growth |
| Trailing P/E | 12.8x reasonably valued |
| Revenue growth | 5.3% slow but positive growth |
| Profit margin | 28.3% healthy profit margins |
| Return on equity | 18.7% a solid return on shareholder capital |
| Debt to equity | 3.87 heavy leverage — higher risk if revenue softens |
| Current ratio | 5.55 comfortably covers its short-term bills |
| Beta | 1.50 moves a little more than the market |
| Market cap | $26.1B |
| Employees | 7,507 |
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on TROW
- › T. Rowe Price (TROW) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks · 13d ago
- › T. Rowe Price Launches Multi-Crypto ETF Including Bitcoin, Ethereum, and XRP 24/7 Wall St. · 13d ago
- › My $1.6 Million Retirement Account Has an Automatic Annuity Clause if I Die: What Are My Options? 24/7 Wall St. · 13d ago
- › Wall Street Deepens Crypto Push as T. Rowe Price Launches Multi-Token ETF and Citadel Securities Invests $400M in Crypto.com CCN · 13d ago
- › Morgan Stanley’s E*Trade Rolls Out Crypto Trading. Wall Street’s Push Into Digital Assets Continues. Barrons.com · 14d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in TROW's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
TROW trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-13 | JACKSON STEPHON A. | Officer | 3,000 | $307,680 | |
| 2026-05-13 | JACKSON STEPHON A. | Officer | 175 | $17,198 | |
| 2026-05-08 | WILSON ALAN D | Director | 1,899 | · | |
| 2026-05-08 | STEVENS ROBERT J | Director | 1,899 | · | |
| 2026-05-08 | SMITH CYNTHIA F | Director | 1,899 | · | |
| 2026-05-08 | ROMINGER EILEEN P. | Director | 1,899 | · | |
| 2026-05-08 | VERMA RICHARD R | Director | 1,899 | · | |
| 2026-05-08 | WIJNBERG SANDRA S | Director | 1,899 | · | |
| 2026-05-08 | DUBLON DINA | Director | 1,899 | · | |
| 2026-05-08 | GOLSTON ALLAN C | Director | 1,899 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $104.75 | +1.6% | · | $1,016 | +1.6% |
| 2 months | $91.49 | +16.3% | · | $1,163 | +16.3% |
| 3 months | $86.62 | +22.9% | $1.30 | $1,244 | +24.4% |
| 6 months | $102.17 | +4.2% | $2.57 | $1,067 | +6.7% |
| 1 year | $91.02 | +16.9% | $5.11 | $1,225 | +22.5% |
| 2 years | $104.19 | +2.2% | $10.10 | $1,118 | +11.8% |
| 3 years | $99.11 | +7.4% | $15.00 | $1,225 | +22.5% |
| 5 years | $154.44 | -31.1% | $27.26 | $866 | -13.4% |
Historical returns from market close data. Past performance does not guarantee future results.